XML 22 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:      
Total revenues $ 722,683 $ 439,442 $ 46,551
Operating expenses:      
Cost of sales - product 262,153 173,572 11,410
Cost of sales - amortization of intangible assets 0 0 2,500
Research and development 46,600 32,228 28,607
Selling, general and administrative 131,408 100,156 79,256
Gain on sale of assets (1,000) (1,000) (6,851)
Total operating expenses 439,161 304,956 114,922
Income (loss) from operations 283,522 134,486 (68,371)
Other income (expense):      
Interest income 7,912 140 1,260
Interest expense (6,732) (11,176) (19,062)
Sublease income 7,685 7,735 7,706
Loss on debt extinguishment 0 (5,232) 0
Change in fair value of warrant liability (Note 14) 1,801 (49,354) 4,124
Other 111 922 (897)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total 294,299 77,521 (75,240)
Provision for income taxes (1,143) (808) 0
Net income (loss) 293,156 76,713 (75,240)
Undistributed earnings allocated to participating securities (283) (4,569) 0
Net income (loss) allocable to common stockholders, basic $ 292,873 $ 72,144 $ (75,240)
Basic net loss per share allocable to common stockholders $ 2.32 $ 0.62 $ (0.75)
Diluted net loss per share allocable to common stockholders $ 1.97 $ 0.57 $ (0.78)
Weighted average shares used to compute basic net loss per share allocable to common stockholders 126,398 116,264 100,753
Weighted average shares used to compute diluted net loss per share allocable to common stockholders 150,797 133,006 101,504
Product      
Revenues:      
Total revenues $ 713,645 $ 437,099 $ 39,307
Other Revenue      
Revenues:      
Total revenues $ 9,038 $ 2,343 $ 7,244